C07C 275/38
Being further substituted by doubly-bound oxygen atoms
Official title: being further substituted by doubly-bound oxygen atoms
C07C275/38 (Being further substituted by doubly-bound oxygen atoms) appears on 69 US grants and 55 published applications in this corpus.
Search patents in C07C- Granted patents
- 69
- Published applications
- 55
- Assignees
- 51
- Inventors
- 280
- Latest grant
- 15 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 1 |
| 2002 | 0 | 4 |
| 2003 | 3 | 2 |
| 2004 | 1 | 7 |
| 2005 | 6 | 6 |
| 2006 | 2 | 1 |
| 2007 | 3 | 1 |
| 2008 | 2 | 5 |
| 2009 | 0 | 3 |
| 2010 | 1 | 2 |
| 2011 | 2 | 2 |
| 2012 | 4 | 5 |
| 2013 | 1 | 1 |
| 2014 | 2 | 2 |
| 2015 | 2 | 2 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 2 | 2 |
| 2020 | 1 | 3 |
| 2021 | 3 | 3 |
| 2022 | 2 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Diarylureas as CB1 allosteric modulators15 Jul 2025US 12,358,869 B2Research Triangle Institute
- Urea motif containing compounds and derivatives thereof as antibacterial drugs7 Jan 2025US 12,187,696 B2Technische Universität München
- Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same22 Nov 2022US 11,504,379 B2Hiroshima University
- Compounds as modulators of TLR2 signaling31 May 2022US 11,345,713 B2Neuropore Therapies, Inc.
- Benzene fused heterocyclic derivative and pharmaceutical composition comprising the same17 Aug 2021US 11,091,421 B2Taiwanj Pharmaceuticals Co., Ltd.
- Compounds as modulators of tlr2 signaling15 Dec 2022US 2022/0396583 A1Neuropore Therapies, Inc.
- Diarylureas as cb1 allosteric modulators28 Oct 2021US 2021/0332007 A1Research Triangle Institute
- Compounds as modulators of tlr2 signaling28 Jan 2021US 2021/0024539 A1Neuropore Therapies, Inc.
- Urea motif containing compounds and derivatives thereof as antibacterial drugs14 Jan 2021US 2021/0009550 A1Technische Universität München
- Novel Amide Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same10 Dec 2020US 2020/0383987 A1Hiroshima University
Most cited
By later US patents
- Guanylhydrazones and their use to treat inflammatory conditions94US 5,854,289 AThe Picower Institute for Medical Research · 1998
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999
- IL-8 receptor antagonists88US 5,780,483 ASmithKline Beecham Corporation · 1998
- 9-substituted minocycline compounds83US 6,846,939 B2Paratek Pharmaceuticals, Inc. · 2005
- IL-8 receptor antagonists76US 6,262,113 B1SmithKline Beecham Corporation · 2001